Terahertz Wave Desensitizes Ferroptosis by Inhibiting the Binding of Ferric Ions to the Transferrin

Ferroptosis is a classic type of programmed cell death characterized by iron dependence, which is closely associated with many diseases such as cancer, intestinal ischemic diseases, and nervous system diseases. Transferrin (Tf) is responsible for ferric-ion delivery owing to its natural Fe3+ binding ability and plays a crucial role in ferroptosis. However, Tf is not considered as a classic druggable target for ferroptosis-associated diseases since systemic perturbation of Tf would dramatically disrupt blood iron homeostasis. Here, we reported a nonpharmaceutical, noninvasive, and Tf-targeted electromagnetic intervention technique capable of desensitizing ferroptosis with directivity. First, we revealed that the THz radiation had the ability to significantly decrease binding affinity between the Fe3+ and Tf via molecular dynamics simulations, and the modulation was strongly wavelength-dependent. This result provides theoretical feasibility for the THz modulation-based ferroptosis intervention. Subsequent extracellular and cellular chromogenic activity assays indicated that the THz field at 8.7 mu m (i.e., 34.5 THz) inhibited the most Fe3+ bound to the Tf, and the wavelength was in good agreement with the simulated one. Then, functional assays demonstrated that levels of intracellular Fe2+, lipid peroxidation, malondialdehyde (MDA) and cell death were all significantly reduced in cells treated with this 34.5 THz wave. Furthermore, the iron deposition, lipid peroxidation, and MDA in the ferroptosis disease model induced by ischemia-reperfusion injury could be nearly eliminated by the same radiation, validating THz wave-induced desensitization of ferroptosis in vivo. Together, this work provides a preclinical exemplar for electromagnetic irradiation-stimulated desensitization of ferroptosis and predicts an innovative, THz wave-based therapeutic method for ferroptosis-associated diseases in the future.